Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

‘Paradigm-shifting’ treatment for pediatric diabetes cleared by FDA

Summary by Yale University
Yale’s Kevan Herold was the senior investigator on a clinical trial which showed that the drug teplizumab — recently approved for pediatric patients with Stage 3 Type 1 diabetes — delays the progression of the disease.

1 Articles

Yale UniversityYale University
Lean Left

‘Paradigm-shifting’ treatment for pediatric diabetes cleared by FDA

Yale’s Kevan Herold was the senior investigator on a clinical trial which showed that the drug teplizumab — recently approved for pediatric patients with Stage 3 Type 1 diabetes — delays the progression of the disease.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Yale University broke the news on Thursday, June 25, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Diabetes icon

Diabetes

FDA icon

FDA

Yale icon

Yale

Research icon

Research

New Haven, Connecticut icon

New Haven, Connecticut

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal